A Study On Drugs Used In Eczema Patients In a Tertiary Care Hospital
Not Applicable
- Conditions
- Health Condition 1: L209- Atopic dermatitis, unspecified
- Registration Number
- CTRI/2020/12/029854
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients diagnosed with eczema aged above 18 years.
Either gender.
Minimum of 2 drugs per prescription.
Exclusion Criteria
Patients not willing to participate in the study.
Incomplete information record.
Pregnant women and lactating mothers.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the prescribing patterns of various class of drugs in eczema patients. <br/ ><br>To study the price variability of different brands of eczema drugs prescribed in the hospital.Timepoint: Single Point
- Secondary Outcome Measures
Name Time Method Helps in understanding prescription practices in eczema. <br/ ><br>Helps in directing future studies and also in developing local policies for appropriate use of drugs in eczema treatment.Timepoint: Single points.